Cargando…
Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194534/ http://dx.doi.org/10.1186/1546-0096-9-S1-P179 |
| _version_ | 1782213993739321344 |
|---|---|
| author | Aggarwal, Amita Myles, Arpita Viswanath, Vishad Singh, Yogesh Preet |
| author_facet | Aggarwal, Amita Myles, Arpita Viswanath, Vishad Singh, Yogesh Preet |
| author_sort | Aggarwal, Amita |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3194534 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31945342011-10-18 Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels Aggarwal, Amita Myles, Arpita Viswanath, Vishad Singh, Yogesh Preet Pediatr Rheumatol Online J Poster Presentation BioMed Central 2011-09-14 /pmc/articles/PMC3194534/ http://dx.doi.org/10.1186/1546-0096-9-S1-P179 Text en Copyright ©2011 Aggarwal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Aggarwal, Amita Myles, Arpita Viswanath, Vishad Singh, Yogesh Preet Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| title | Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| title_full | Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| title_fullStr | Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| title_full_unstemmed | Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| title_short | Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels |
| title_sort | soluble receptor for advanced glycation end products (srage) is decreased in patients with juvenile idiopathic arthritis (era category) and inversely correlates with disease activity and s100a12 levels |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194534/ http://dx.doi.org/10.1186/1546-0096-9-S1-P179 |
| work_keys_str_mv | AT aggarwalamita solublereceptorforadvancedglycationendproductssrageisdecreasedinpatientswithjuvenileidiopathicarthritiseracategoryandinverselycorrelateswithdiseaseactivityands100a12levels AT mylesarpita solublereceptorforadvancedglycationendproductssrageisdecreasedinpatientswithjuvenileidiopathicarthritiseracategoryandinverselycorrelateswithdiseaseactivityands100a12levels AT viswanathvishad solublereceptorforadvancedglycationendproductssrageisdecreasedinpatientswithjuvenileidiopathicarthritiseracategoryandinverselycorrelateswithdiseaseactivityands100a12levels AT singhyogeshpreet solublereceptorforadvancedglycationendproductssrageisdecreasedinpatientswithjuvenileidiopathicarthritiseracategoryandinverselycorrelateswithdiseaseactivityands100a12levels |